Publications by authors named "Awet Abraha"

Claim this Profile
D
Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage.
Immaculate L Nankya, Denis M Tebit, Awet Abraha, Fred Kyeyune, Richard Gibson

AIDS Res Ther· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in Argentina.
Andrea E Rubio, Awet Abraha, Crystal A Carpenter, Ryan M Troyer, Ángel L Reyes-Rodríguez

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrichment of intersubtype HIV-1 recombinants in a dual infection system using HIV-1 strain-specific siRNAs.
Yong Gao, Measho Abreha, Kenneth N Nelson, Heather Baird, Dawn M Dudley, Awet Abraha

Retrovirology· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.
Awet Abraha, Immaculate L Nankya, Richard Gibson, Korey Demers, Denis M Tebit

J Virol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
Ryan M Troyer, John McNevin, Yi Liu, Shao Chong Zhang, Randall W Krizan, Awet Abraha

PLoS Pathog· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calculating HIV-1 infectious titre using a virtual TCID(50) method.
Yong Gao, Immaculate Nankya, Awet Abraha, Ryan M Troyer, Kenneth N Nelson

Methods Mol Biol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replication.
Yong Gao, Michael A Lobritz, Justin Roth, Measho Abreha, Kenneth N Nelson, Awet Abraha

J Virol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.
Nicaise Ndembi, Awet Abraha, Heather Pilch, Hiroshi Ichimura, Dora Mbanya

J Clin Microbiol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods to determine HIV-1 ex vivo fitness.
Awet Abraha, Ryan M Troyer, Miguel E Quiñones-Mateu, Eric J Arts

Methods Mol Biol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.
Kevin K Ariën, Awet Abraha, Miguel E Quiñones-Mateu, Luc Kestens, Guido Vanham

J Virol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression.
Ryan M Troyer, Kalonji R Collins, Awet Abraha, Erika Fraundorf, Dawn M Moore

J Virol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry.
Andre J Marozsan, Dawn M Moore, Michael A Lobritz, Erika Fraundorf, Awet Abraha

J Virol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.
Andre J Marozsan, Erika Fraundorf, Awet Abraha, Heather Baird, Dawn Moore

J Virol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
Tatsuyoshi Kawamura, Shannon E Bruse, Awet Abraha, Makoto Sugaya, Oliver Hartley

J Virol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.
Nathalie Richard, Marisa Juntilla, Awet Abraha, Korey Demers, Ellen Paxinos

AIDS Res Hum Retroviruses· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.
Sarah C Ball, Awet Abraha, Kalonji R Collins, Andre J Marozsan, Heather Baird

J Virol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.
Miguel E Quiñones-Mateu, Yong Gao, Sarah C Ball, Andre J Marozsan, Awet Abraha

J Virol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis